Cost-Utility Analysis of Cataract Surgery in the Second Eye

Ophthalmology

Volumn 110, Issue 12, 2003, Pages 2310-2317

  Busbee, Brandon G ^a,b,c,e   Brown, Melissa M ^a   Brown, Gary C ^a   Sharma, Sanjay ^a,d  

^a WILLS EYE HOSPITAL   (United States)

^b TUFTS UNIVERSITY   (United States)

^c OPHTHALMIC CONSULTANTS OF BOSTON   (United States)

^d Queens Medical College   (Canada)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ENDOPHTHALMITIS; FEMALE; HUMAN; KERATOPATHY; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOPHAKIA; QUALITY ADJUSTED LIFE YEAR; RETINA MACULA CYSTOID EDEMA; VISUAL ACUITY;

EID: 0037583136     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00796-6     Document Type: Article

References (71)

1. Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol 1993;111:1041-9.
2. Javitt JC, Steinberg EP, Sharkey P, et al. Cataract surgery in one eye or both. A billion dollar per year issue. Ophthalmology 1995;102:1583-92.
3. Cataract Management Guideline Panel, United States. Cataract in Adults. Management of Functional Impairment, Clinical Practice Guideline, Number 4. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, United States Department of Health and Human Services; 1993. AHCPR Publication 93-0542.
4. Norregaard JC, Hindsberger C, Alonso J, et al. Visual outcomes of cataract surgery in the United States, Canada, Denmark, and Spain. Report from the International Cataract Surgery Outcomes Study. Arch Ophthalmol 1998;116:1095-100.
5. Lum F, Schein O, Schachat AP, et al. Initial two years of experience with the AAO National Eyecare Outcomes Network (NEON) cataract surgery database. Ophthalmology 2000;107:691-7.
6. Klein BE, Klein R, Moss SE. Change in visual acuity associated with cataract surgery. The Beaver Dam Eye Study. Ophthalmology 1996;103:1727-31.
7. Cassard SD, Patrick DL, Damiano AM, et al. Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Arch Ophthalmol 1995;113:1508-13.
8. Steinberg EP, Tielsch JM, Schein OD, et al. National study of cataract surgery outcomes. Variation in 4-month postoperative outcomes as reflected in multiple outcome measures. Ophthalmology 1994;101:1131-41.
9. Monestam E, Wachtmeister L. Impact of cataract surgery on car driving: a population based study in Sweden. Br J Ophthalmol 1997;81:16-22.
10. Brenner MH, Curbow B, Javitt JC, et al. Vision change and quality of life in the elderly. Response to cataract surgery and treatment of other chronic ocular conditions. Arch Ophthalmol 1993;111:680-5.
11. Applegate WB, Miller ST, Elam JT, et al. Impact of cataract surgery with lens implantation on vision and physical function in elderly patients. JAMA 1987;257:1064-6.
12. Bernth-Petersen P. Visual functioning in cataract patients. Methods of measuring and results. Acta Ophthalmol 1981;59:198-205.
13. Busbee BG, Brown MM, Brown GC, et al. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 2002;109:606-12.
14. Health Care Financing Administration. National health expenditures amounts by type of expenditure and source of funds. Calendar year health spending projections, 1998-2008. Available at: http://www.hcfa.gov. Accessed September 1, 2001.
15. Javitt JC, Brenner MH, Curbow B, et al. Outcomes of cataract surgery. Improvement in visual acuity and subjective visual function after surgery in the first, second, and both eyes. Arch Ophthalmol 1993;111:686-91.
16. Talbot EM, Perkins A. The benefit of second eye cataract surgery. Eye 1998;12:983-9.
17. Elliott DB, Patla A, Bullimore MA. Improvements in clinical and functional vision and perceived visual disability after first and second eye cataract surgery. Br J Ophthalmol 1997;81:889-95.
18. Kwapiszeski BR, Gallagher CC, Holmes JM. Improved stereoacuity: an indication for unilateral cataract surgery. J Cataract Refract Surg 1996;22:441-5.
19. Claridge KG, Francis PJ, Bates AK. Should second eye cataract surgery be rationed? Eye 1995;9:47-9.
20. Laidlaw A, Harrad R. Can second eye cataract extraction be justified? Eye 1993;7:680-6.
21. Laidlaw D, Harrad RA, Hopper CD, et al. Randomised trial of effectiveness of second eye cataract surgery. Lancet 1998;352:925-9.
22. Desai P, Reidy A, Minassian DC, et al. Gains from cataract surgery: visual function and quality of life. Br J Ophthalmol 1996;80:868-73.
23. Castells X, Alonso J, Ribo C, et al. Comparison of the results of first and second cataract eye surgery. Ophthalmology 1999;106:676-82.
24. Mangione CM, Phillips RS, Lawrence MG, et al. Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol 1994;112:1419-25.
25. Rubin GS, Bandeen-Roche K, Huang GH, et al. The association of multiple visual impairments with self-reported visual disability: SEE project. Invest Ophthalmol Vis Sci 2001;42:64-72.
26. Broman AT, Munoz B, West SK, et al. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER. Invest Ophthalmol Vis Sci 2001;42:606-13.
27. Ellwein LB, Friedlin V, McBean M, Lee PP. Use of eye care services among the 1991 Medicare population. Ophthalmology 1996;103:1732-43.
28. Brown GC. Vision and quality-of-life. Trans Am Ophthalmol Soc 1999;97:473-511.
29. Brown GC, Sharma S, Brown MM, et al. Evidence-based medicine and cost-effectiveness. J Health Care Finance 1999;26:14-23.
30. Brown MM, Brown GC, Sharma S, et al. Evidence-based medicine, utilities, and quality of life. Curr Opin Ophthalmol 1999;10:221-6.
31. Brown MM, Brown GC. Cost-effective analysis. The value component of evidence-based medicine. Evidence-Based Eye Care 2000;1:243-7.
32. Drummond MF, O'Brien BJ, Stoddard GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. New York: Oxford University Press; 1997:52-204.
33. Torrance GW. Utility approach to measuring health-related quality of life [review]. J Chronic Dis 1987;40:593-603.
34. Weinstein MC, Stasson WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716-21.
35. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989;5:559-75.
36. Wyatt JR, Niparko JK, Rothman M, et al. Cost utility of the multichannel cochlear implants in 258 profoundly deaf individuals. Laryngoscope 1996;106:816-21.
37. Pinkerton SD, Holtgrave DR, Pinkerton HJ. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med 1997;157:1972-80.
38. Jacobson JJ, Schweitzer SO, Kowalski CJ. Chemoprophylaxis of prosthetic joint patients during dental treatment: a decision-utility analysis. Oral Surg Oral Med Oral Pathol 1991;72:167-77.
39. Kent KC, Kuntz KM, Patel MR, et al. Perioperative imaging strategies for carotid endarterectomy. An analysis of morbidity and cost-effectiveness in symptomatic patients. JAMA 1995;274:888-93.
40. Brown MM, Brown GC, Sharma S, et al. Utility values and diabetic retinopathy. Am J Ophthalmol 1999;128:324-30.
41. Brown GC, Brown MM, Sharma S, et al. Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization. Ophthalmology 2000;107:1374-80.
42. Brown GC, Brown MM, Sharma S, et al. Incremental cost-effectiveness of laser therapy for choroidal neovascularization associated with histoplasmosis. Retina 2000;20:331-7.
43. Brown GC, Brown MM, Sharma S, et al. Cost-effectiveness of therapy for threshold retinopathy of prematurity. Pediatrics 1999;104:e47-64.
44. Brown GC, Sharma S, Brown MM, et al. Utility values and age-related macular degeneration. Arch Ophthalmol 2000;118:47-51.
45. Brown MM, Brown GC, Sharma S, et al. Quality of life associated with unilateral and bilateral good vision. Ophthalmology 2001;108:643-8.
46. Schaumberg DA, Dana MR, Cristen WG, et al. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology 1998;105:1213-21.
47. Powe NR, Schein OD, Gieser SC, et al. Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Arch Ophthalmol 1994;112:239-52.
48. Javitt JC, Street DA, Tielsch JM, et al. National outcomes of cataract extraction. Retinal detachment and endophthalmitis after outpatient cataract surgery. Cataract Patient Outcomes Research Team. Ophthalmology 1994;101:100-6.
49. Data TM 3.5 Healthcare User's Manual. Williamstown, MA: Treeage Software, Inc.; 1999.
50. Detsky AS, Naglie G, Krahn MD, et al. Primer on medical decision analysis: part 2-building a tree. Med Decis Making 1991;17:126-35.
51. Anderson RN. United States life tables, 1997. Natl Vital Stat Rep 1999;47:1-38.
52. Kirschner CG, Davis SJ, Duffy T, et al. Current Procedural Terminology 2001. Chicago: American Medical Association; 2000.
53. Davis JB, ed. Medical Fees in the United States 2000. Nationwide Charges for Medicine, Surgery, Laboratory, Radiology and Allied Health Services. Los Angeles: Practice Management Information Corp; 2000.
54. Cohen HE, ed. 2001 Drug Topics Red Book. Montvale, NJ: Medical Economics Company; 2001.
55. Medicare statistics. Available at: http://www.hfca.gov/stats. Accessed: September 1, 2001.
56. 2001 Relative Value Guide. A Guide for Anesthesia Values. Park Ridge, IL: American Society of Anesthesiologists; 2001.
57. Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. Surv Ophthalmol 1992;37:73-116.
58. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-96.
59. Mello MO Jr, Scott IU, Smiddy WE, et al. Surgical management and outcomes of dislocated intraocular lenses. Ophthalmology 2000;107:62-7.
60. Cohen EJ, Brady SE, Leavitt K, et al. Pseudophakic bullous keratopathy. Am J Ophthalmol 1988;106:264-9.
61. Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992;146:473-81.
62. Brown MM, Brown GC, Sharma S, et al. Physician manpower and health care expenditures in the United States: thirty-year perspective. J Health Care Finance 2001;27:55-64.
63. World Health Organization Assesses the World's Health Systems. Available at: http://who.int/whr/2000/en/pressrelease.htm. Accessed September 1, 2001.
64. Redelmeier DA, Detsky AS. A clinician's guide to utility measurement. In: Bergus GR, Cantor SB, eds. Primary Care Clinics in Office Practice. Philadelphia: Saunders; 1995;280.
65. Rothwell PM, McDowell Z, Wong CK, et al. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 1997;314:1580-3.
66. Lunde IM. Patients' perceptions-a shift in medical perspective. Scand J Prim Health Care 1993;11:98-104.
67. Brown GC, Brown MM, Sharma S. Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration. Can J Ophthalmol 2000;35:127-33.
68. Kassirer JP. Incorporating patients' preferences into medical decisions. N Engl J Med 1994;330:1895-6.
69. Brown MM, Brown GC. Outcome of corneal transplantation. Value-based health care. Br J Ophthalmol 2002;86:2-3.
70. Doyle RL. Healthcare Management Guidelines, Volume 1. Inpatient and Surgical Care. Washington: Milliman and Robertson, Inc.; 1992.
71. Brown MM, Brown GC, Sharma S, et al. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol 2002;120:481-4.